Gå til innholdet
Menu

Zoetis Completes Purchase of PHARMAQ, the Global Leader in Vaccines and Innovation for Health Products in Aquaculture

FLORHAM PARK, N.J. - November 10, 2015 - Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, for a price of $765 million on a debt-free basis, having fulfilled all closing requirements.    

November 10, 2015

Zoetis Media Contacts                                             

Bill Price
973-443-2742 
William.price@zoetis.com                                       

Elinore White                                                            
973-443-2835                                                         
Elinore.y.white@zoetis.com   

PHARMAQ Media Cotact

Tore Valderhaug
+47 99 56 09 25
tore.valderhaug@pharmaq.no

Zoetis Investor Contacts

John O`Connor
973-822-7088
john.oconnor@zoetis.com

Steve Frank
973-822-7141
steve.frank@zoetis.com


Zoetis purchased PHARMAQ from a company owned by Permira IV, a fund managed by the global investment firm Permira, which has been the majority owner of the company since 2013. 

“We are very pleased to welcome the PHARMAQ team to Zoetis, and we look forward to the future success we can build together as a market leader in aquatic health,” said Zoetis Chief Executive Officer Juan Ramón Alaix. “The PHARMAQ people, products and late-stage pipeline give Zoetis a strong platform for growth in the fastest growing animal health market.”

Zoetis plans to run the PHARMAQ business largely as a stand-alone operation within the company to help maintain its focus on critical customer needs and R&D milestones that will assure continued success.   

About Zoetis

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in 120 countries. For more information, visit www.zoetis.com.

About PHARMAQ

PHARMAQ is the world's leading pharmaceutical company supplying the aquaculture industry and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. The vaccines are manufactured in a state of the art production facility in Overhalla and Oslo, Norway. Administration and research and development activities are based in Oslo with subsidiaries in Norway, Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, please visit our website: www.pharmaq.no/.   

DISCLOSURE NOTICES

Forward-Looking Statements:  This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, expectations regarding products, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.  A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis. 

 

 


Did you know...

WE MAKE AQUACULTURE PROGRESS

Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.

»
»
»
»
»
»
»
»
»
»

Norway

PHARMAQ AS
Head office/
Production facility
Skogmo Industriområde
Industrivegen 50
N-7863 Overhalla, Norway
Tel:+47 74 28 08 00
customer.service​@pharmaq.no


PHARMAQ AS
Production facility
Dyrskuevien 13, 2040 Kløfta
P.O.Box 152, N-2041 Kløfta, Norway
Tel: +47 23 29 85 00
customer.service​@pharmaq.no

   

PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo
P.O.Box 267 Skøyen
N-0213 Oslo, Norway
Tel: +47 23 29 85 00
customer.service​@pharmaq.no

   

PHARMAQ Analytiq
Thormøhlensgate 53D
N-5008 Bergen, Norway
Tel: (+47) 23 29 85 00
kontakt@analytiq.no

   

PHARMAQ Fishteq
Havneveien 6
N-8700 Nesna, Norway
Tel:+47 941 63 150
PHQ.fishteqsupport@zoetis.com

Chile

PHARMAQ AS Chile Ltda.
Bernardino # 1981, Piso 2, Oficina 202,
Parque Empresarial San Andrés,
Puerto Montt, Chile
Tel: +56 65 248 3091
customer.service​@pharmaq.no

 

United Kingdom

PHARMAQ Ltd.
Unit 15 Sandleheath Industrial Estate,
Fordingbridge,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
orders@pharmaq.no

Terms & Conditions of Purchase
Terms & Conditions of Sale
Tax strategy and Disclosure: Financial year ending 30 November 2017

Turkey

PHARMAQ Veteriner Ecza Deposu ve Su Ürünleri Tic.Ltd.Şti
KARACAOGLAN MAH. 6166 SK. 21 A BORNOVA/ IZMIR Turkiye
Tel: +90 232 422 23 10
customer.service​@pharmaq.no

Vietnam

PHARMAQ Ltd. VN
R. 2503, 25th Fl., Viettel Tower
285 Cach Mang Thang Tom
W.12, D10, HCMC, Vietnam
Tel : +84 28 6284 5350
customer.service​@pharmaq.no

Panama

Zoetis Panamá / PHARMAQ Panamá
Piso 2. Oficina 108. P.H. Albrook Commercial Park
Ave. Bella Vista, Ancón, Panamá
PO. Box: 0832-0588
Phone: +507 3215363
Mob.: +507 6675 1109
customer.service​@pharmaq.no

Spain

PHARMAQ Spain Aqua
Avda de Europa 20B
Parque Empresarial La Moraleja
28108 Alcobendas, Spain
Tel: +34 91 419 19 35
customer.service​@pharmaq.no

Singapore

PHARMAQ part of Zoetis
108 Pasir Panjang Road
Singapore 118535, Singapore
Tel.: +65 6933 5800
customer.service​@pharmaq.no

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.comPrivacy Policy. Cookie Policy. Terms of Use.

Copyright © 2016 Zoetis LLC. All rights reserved.

Utviklet av Imaker as